A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2006
10/26/2006	DE10163667B4 Verwendung von Desoxypeganin zur Behandlung der klinischen Depression Use of deoxypeganine for the treatment of clinical depression
10/26/2006	CA2605967A1 Topiramate compositions for treatment of headache
10/26/2006	CA2605421A1 Functions and uses of gpr39 gene in central nervous system in mammals
10/26/2006	CA2605410A1 A therapeutic agent for a .beta. related disorders
10/26/2006	CA2605059A1 Oxindole compounds and their uses as therapeutic agents
10/26/2006	CA2604956A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
10/26/2006	CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism
10/26/2006	CA2603920A1 Pharmacological treatment for sleep apnea
10/26/2006	CA2602247A1 Piperazine-substituted benzothiophenes for treatment of mental disorders
10/25/2006	EP1714655A1 Use of sodium channel blockers and their analogues for the treatment of nicotine dependency
10/25/2006	EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm
10/25/2006	EP1714650A1 Arginine-containing compositions for increasing blood flow
10/25/2006	EP1714648A1 Combination drug
10/25/2006	EP1714647A1 Use of agomelatin in the manufacture of a medicament for the treatment of bipolar disorders
10/25/2006	EP1713810A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
10/25/2006	EP1713809A1 Dimeric azacyclic compounds and their use
10/25/2006	EP1713797A1 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE DERIVATIVES HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY
10/25/2006	EP1713791A1 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5
10/25/2006	EP1713784A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
10/25/2006	EP1713780A2 Novel inhibitors of glutaminyl cyclase
10/25/2006	EP1713778A1 Benzazepine derivatives as histamine h3 antagonists
10/25/2006	EP1713768A2 Novel crystalline forms of entacapone and production thereof
10/25/2006	EP1713494A2 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists
10/25/2006	EP1713488A1 Treatment of psychoses with quetiapine antipsychotic
10/25/2006	EP1713487A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators
10/25/2006	EP1713486A1 Combination therapy for dementia,depression and apathy
10/25/2006	EP1713482A1 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-2s-phenyl-piperidin-3s-yl)-amine for the treatment of social phobia
10/25/2006	EP1713480A2 The use of quaternary pyridinium salts as vasoprotective agents
10/25/2006	EP1713475A1 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/25/2006	EP1713463A2 Reelin deficiency or dysfunction and methods related thereto
10/25/2006	EP1713459A2 Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases
10/25/2006	EP1713451A1 Solid dosage formulations of galanthamine
10/25/2006	EP1590346B1 4- {'3-(sulfonylamino) phenyl] '1-(cyclymethyl) piperidin-4-ylidene] methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
10/25/2006	EP1567501B1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
10/25/2006	EP1532152B1 Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl\|-pyrazol- 1,5-alpha\|-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto
10/25/2006	EP1524971B1 Improved transdermal delivery system
10/25/2006	EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/25/2006	EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
10/25/2006	EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006	EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
10/25/2006	EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists
10/25/2006	EP1313476B1 Sgk3 used as diagnostic and therapeutic target
10/25/2006	EP1286672B1 S-methyl-dihydro-ziprasidone for the treatment of ocular disorders.
10/25/2006	EP1278522B1 Pde-v inhibitors for treatment of parkinson's disease
10/25/2006	EP1265849B1 Compounds and methods to treat alzheimer's disease
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1187613B9 Amide substituted imidazoquinolines
10/25/2006	EP1157006B1 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	EP1097167B1 Neurotrophic growth factor
10/25/2006	EP0912086B1 Method of screening for drugs for the treatment of alzheimer's disease
10/25/2006	EP0827408B1 Method of administration of igf-i
10/25/2006	CN1852971A Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
10/25/2006	CN1852897A Gabanergic modulators
10/25/2006	CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
10/25/2006	CN1852723A Use of pelargonium plant extracts
10/25/2006	CN1852709A Macrophage activation inhibitor
10/25/2006	CN1852706A Combination of a serotonin reuptake inhibitors and agomelatine
10/25/2006	CN1850851A Method for preparing total saponins from theroots of platycodon grandiflorum utilizing weak polarity macroreticular resin and its use
10/25/2006	CN1850836A Celosia argentea suponin compound and its pharmaceutical use
10/25/2006	CN1850820A Coumarin derivatives, and their preparing method and use as alpha, receptor agonist
10/25/2006	CN1850804A Optical-purity meptazinol orits salts, and preparing method
10/25/2006	CN1850766A Method for extracting hypericin
10/25/2006	CN1850275A Chiral drug intercalation hydrotalcite and its preparing method
10/25/2006	CN1850269A Function of GPR39 gene for central nervous system of mammal and its use
10/25/2006	CN1850255A Medicine composition and preparing method
10/25/2006	CN1850250A Abstinence wine
10/25/2006	CN1850241A Dispersible tablet of Vitamin C and Lonicera and Forsythia and preparing method thereof
10/25/2006	CN1850221A Medicine composition for treating rheumatoid arthritis and rheumatism
10/25/2006	CN1850218A Chinese medicine composition for treating optic atrophy and preparing method therefor
10/25/2006	CN1850212A Valerianoil liquid hard capsule, and its preparing method
10/25/2006	CN1850180A Plaster for treating facial palsy and preparing method
10/25/2006	CN1850169A Melissa powder composition with function of preventing and treating prostate disease and relative diseases
10/25/2006	CN1850140A Method for preparing chrysanthemum formula granules
10/25/2006	CN1850115A Method for preparing bear's gall dropping pills
10/25/2006	CN1850093A Stibene-glucoside oral liquid and its production method
10/25/2006	CN1850077A Lappaconitine hydrobromide dispersible tablet and its preparing method
10/25/2006	CN1850064A Preparation for relieving stress symptom
10/25/2006	CN1281616C Compound extracted from hull and stem of yellow horn, extracting method and application
10/25/2006	CN1281613C Chinese medicine gelsmium elegans total alkaloid for anticancer and analgesia, and medicinal composition containing it and preparing method thereof
10/25/2006	CN1281608C New azo-indolyl derivatives
10/25/2006	CN1281607C Quaternary ammonium salt compound of piperazine with pain relieving effect
10/25/2006	CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281274C 6-fluorobicyclo [3.1.0] hexane derivatives
10/25/2006	CN1281269C Chinese medicine preparation for quickly-stopping addiction and curing abstinence syndrome and its preparation method
10/25/2006	CN1281264C Medicine for treating epilepsia and its preparing method
10/25/2006	CN1281238C External-applied medicine for treating terminal neuritis and preparation thereof
10/25/2006	CN1281234C Headache treating Chinese medicine
10/25/2006	CN1281227C Bunao Yishen Runchang Capsule for replenishing brain and kidney and moistening intestines
10/25/2006	CN1281226C Pain-dispersing emplastrum
10/25/2006	CN1281215C The second purpose of Siberian solomonseal rhizome polysaccharide
10/24/2006	US7126027 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006	US7125911 Autonomic nerve regulating agent
10/24/2006	US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2

1 ... 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 ... 1833